Using real world evidence in medical cannabis
By Mike Morgan-Giles, CEO, Cannabis Industry Council The challenges of developing extensive clinical trials for cannabis are well known within the industry, but perhaps less so among policy makers, regulators, and even doctors on the periphery. A range of factors contribute to this, including high start-up costs, complex and somewhat illogical regulations, and the need […]
Read More